1. Home
  2. PDS vs LQDA Comparison

PDS vs LQDA Comparison

Compare PDS & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PDS
  • LQDA
  • Stock Information
  • Founded
  • PDS 1951
  • LQDA 2004
  • Country
  • PDS Canada
  • LQDA United States
  • Employees
  • PDS N/A
  • LQDA N/A
  • Industry
  • PDS
  • LQDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • PDS
  • LQDA Health Care
  • Exchange
  • PDS Nasdaq
  • LQDA Nasdaq
  • Market Cap
  • PDS 998.3M
  • LQDA 929.0M
  • IPO Year
  • PDS N/A
  • LQDA 2018
  • Fundamental
  • Price
  • PDS $62.23
  • LQDA $9.84
  • Analyst Decision
  • PDS Buy
  • LQDA Strong Buy
  • Analyst Count
  • PDS 1
  • LQDA 8
  • Target Price
  • PDS $95.00
  • LQDA $27.14
  • AVG Volume (30 Days)
  • PDS 101.6K
  • LQDA 751.9K
  • Earning Date
  • PDS 10-29-2024
  • LQDA 11-13-2024
  • Dividend Yield
  • PDS N/A
  • LQDA N/A
  • EPS Growth
  • PDS 62.11
  • LQDA N/A
  • EPS
  • PDS 12.37
  • LQDA N/A
  • Revenue
  • PDS $1,436,787,445.00
  • LQDA $15,610,000.00
  • Revenue This Year
  • PDS $4.34
  • LQDA N/A
  • Revenue Next Year
  • PDS $3.31
  • LQDA $227.73
  • P/E Ratio
  • PDS $4.87
  • LQDA N/A
  • Revenue Growth
  • PDS N/A
  • LQDA N/A
  • 52 Week Low
  • PDS $49.67
  • LQDA $6.19
  • 52 Week High
  • PDS $79.07
  • LQDA $16.99
  • Technical
  • Relative Strength Index (RSI)
  • PDS 50.03
  • LQDA 33.81
  • Support Level
  • PDS $61.92
  • LQDA $10.17
  • Resistance Level
  • PDS $65.15
  • LQDA $10.95
  • Average True Range (ATR)
  • PDS 2.12
  • LQDA 0.39
  • MACD
  • PDS 0.35
  • LQDA -0.13
  • Stochastic Oscillator
  • PDS 62.13
  • LQDA 3.79

About PDS Precision Drilling Corporation

Precision Drilling Corpd is a provider of contract drilling and completion and production services to oil and natural gas exploration and production companies in Canada, the United States and certain international locations. Contract Drilling Services include drilling rigs, procurement and distribution of oilfield supplies, and the manufacture, sale and repair of drilling equipment. Completion and Production Services include service rigs, oilfield equipment rental, and camp and catering services.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

Share on Social Networks: